5691 - 5700 of 9033 Results
Title
Year
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7719613Citation Count: 127
- Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex2012RESTRICTEDTitle: Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complexJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 242End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.05.017Citation Count: 42
-
OPENTitle: Structural changes in early-stage Parkinson’s disease with resting tremor at node, edge and network levelJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 220Issue #:Start Page: 111169End Page: 111169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brainresbull.2024.111169Best OA location URL: https://doi.org/10.1016/j.brainresbull.2024.111169Citation Count: 1
-
OPENTitle: Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 10Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.338Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.338Citation Count: 611
-
OPENTitle: Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1655End Page: 1667Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29510Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29510Citation Count: 18
-
OPENTitle: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.70672Best OA location URL: https://doi.org/10.1002/mdc3.70672Citation Count: 0
-
OPENTitle: Alpha galactosidase A activity in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.012Best OA location URL: https://doaj.org/article/2d3c35c920664143a7a6fbfadca77476Citation Count: 81
- Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease2018RESTRICTEDTitle: Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative diseaseJournal Name: Current Opinion in ToxicologyPublisher: Elsevier BVVol: 7Issue #:Start Page: 127End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cotox.2018.02.003Citation Count: 21
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4434483Citation Count: 57
- DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.2017RESTRICTEDTitle: DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.Journal Name: NeuropharmacologyPublisher: Elsevier BVVol: 131Issue #:Start Page: 116End Page: 127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.11.046Citation Count: 20